J Stroke.  2021 Jan;23(1):132-134. 10.5853/jos.2020.04112.

Eighteen-Year Disease Progression and Survival in CADASIL

• Gravesteijn G
• Hack RJ
• Opstal AMv
• van Eijsden BJ
• Middelkoop HA
• Rodriguez Girondo MD
• Aartsma-Rus A
• Grond Jvd
• Rutten JW
• Oberstein SAL

• KMID: 2512363
• DOI: http://doi.org/10.5853/jos.2020.04112

Reference

References

1. Rutten JW, Van Eijsden BJ, Duering M, Jouvent E, Opherk C, Pantoni L, et al. The effect of NOTCH3 pathogenic variant position on CADASIL disease severity: NOTCH3 EGFr 1-6 pathogenic variant are associated with a more severe phenotype and lower survival compared with EGFr 7-34 pathogenic variant. Genet Med. 2019; 21:676–682.

2. Adib-Samii P, Brice G, Martin RJ, Markus HS. Clinical spectrum of CADASIL and the effect of cardiovascular risk factors on phenotype: study in 200 consecutively recruited individuals. Stroke. 2010; 41:630–634.

3. van den Boom R, Lesnik Oberstein SA, Ferrari MD, Haan J, van Buchem MA. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy: MR imaging findings at different ages. 3rd-6th decades. Radiology. 2003; 229:683–690.

4. Jouvent E, Duchesnay E, Hadj-Selem F, De Guio F, Mangin JF, Hervé D, et al. Prediction of 3-year clinical course in CADASIL. Neurology. 2016; 87:1787–1795.